3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 8,190,396 shares, a decrease of 40.6% from the September 15th total of 13,790,396 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.
3SBio Stock Performance
Shares of TRSBF stock opened at $1.90 on Thursday. 3SBio has a 12-month low of $1.90 and a 12-month high of $4.74. The firm has a 50 day moving average price of $2.12 and a two-hundred day moving average price of $2.36.
3SBio Company Profile
3SBio Inc is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of biologic medicines. Its portfolio primarily serves therapeutic areas including nephrology, oncology, autoimmune diseases and other conditions requiring specialized biologic treatments.
The company’s products include recombinant human erythropoietin products used to treat anemia, recombinant human growth hormone, and thrombopoietin therapies designed to support platelet production.
See Also
- Five stocks we like better than 3SBio
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
